Spire Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Sell |
844
-142
| -14% | -$2.2K | ﹤0.01% | 1639 |
|
|
2025
Q1 | $14.7K | Sell |
986
-117
| -11% | -$1.74K | ﹤0.01% | 1714 |
|
|
2024
Q4 | $14.6K | Buy |
1,103
+274
| +33% | +$3.63K | ﹤0.01% | 1727 |
|
|
2024
Q3 | $11.8K | Buy |
829
+687
| +484% | +$9.77K | ﹤0.01% | 1593 |
|
|
2024
Q2 | $1.84K | Buy |
142
+42
| +42% | +$543 | ﹤0.01% | 2022 |
|
|
2024
Q1 | $1.39K | Sell |
100
-42
| -30% | -$583 | ﹤0.01% | 2153 |
|
|
2023
Q4 | $2.09K | Hold |
142
| – | – | ﹤0.01% | 2132 |
|
|
2023
Q3 | $2.2K | Hold |
142
| – | – | ﹤0.01% | 2116 |
|
|
2023
Q2 | $2.23K | Sell |
142
-33
| -19% | -$518 | ﹤0.01% | 2179 |
|
|
2023
Q1 | $2.88K | Buy |
175
+42
| +32% | +$692 | ﹤0.01% | 2174 |
|
|
2022
Q4 | $2K | Hold |
133
| – | – | ﹤0.01% | 2106 |
|
|
2022
Q3 | $2K | Sell |
133
-233
| -64% | -$3.5K | ﹤0.01% | 1997 |
|
|
2022
Q2 | $5K | Sell |
366
-109
| -23% | -$1.49K | ﹤0.01% | 2150 |
|
|
2022
Q1 | $7K | Sell |
475
-53
| -10% | -$781 | ﹤0.01% | 2165 |
|
|
2021
Q4 | $7K | Sell |
528
-39
| -7% | -$517 | ﹤0.01% | 2496 |
|
|
2021
Q3 | $9K | Sell |
567
-629
| -53% | -$9.98K | ﹤0.01% | 2134 |
|
|
2021
Q2 | $20K | Sell |
1,196
-492
| -29% | -$8.23K | ﹤0.01% | 1872 |
|
|
2021
Q1 | $31K | Buy |
+1,688
| New | +$31K | ﹤0.01% | 1961 |
|